FDA Kicks Off Kratom Enforcement With $400,000 Seizure In Illinois
This article was originally published in The Tan Sheet
Executive Summary
The seizure targets some 90,000 bottles of RelaKzpro brand products marketed by Dordoniz Natural Products in Illinois, the home state of Sen. Dick Durbin, who is critical of FDA's supplement market enforcement and plans legislation for tighter regulation.
You may also be interested in...
FDA's Opioid Label For Kratom Called Misbranding By Marketers
"Based on the scientific information in the literature and further supported by our computational modeling and the reports of its adverse effects in humans, we feel confident in calling compounds found in kratom, opioids," says Commissioner Scott Gottlieb.
Health & Wellness Industry News Roundup: Week Of Aug. 1
Kratom seized again; FTC warns on Zika claims; EntereoMed passes 2 of 3 UK gut health claim checks; Bevolution adds Dr. Smoothie to lineup; physicians committee recommends prebiotics; and more news in brief.
Kratom Action Presents Regulatory Puzzle For FDA
The agency is seizing imports of kratom but industry seeks to clarify whether the substance, which in large doses can have narcotic effects, can be used in dietary supplements. Because FDA acknowledges kratom is a dietary ingredient, a ban as used for ephedra action may be up for consideration.